PT - JOURNAL ARTICLE AU - Lee Worden AU - Rae Wannier AU - Micaela Neus AU - Jennifer C. Kwan AU - Alex Y. Ge AU - Eugene T. Richardson AU - Travis Porco TI - Estimation of COVID-19 transmission rates in California and the U.S. with reporting delays AID - 10.1101/2020.05.14.20101162 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.14.20101162 4099 - http://medrxiv.org/content/early/2020/05/19/2020.05.14.20101162.short 4100 - http://medrxiv.org/content/early/2020/05/19/2020.05.14.20101162.full AB - We estimated time-varying reproduction numbers of COVID-19 transmission in counties and regions of California and in states of the United States, using the Wallinga-Teunis method of estimations applied to publicly available data. The serial interval distribution assumed incorporates wide uncertainty in delays from symptom onset to case reporting. This assumption contributes smoothing and a small but meaningful increase in numerical estimates of reproduction numbers due to the likely existence of secondary cases not yet reported. Transmission in many areas of the U.S. may not yet be controlled, including some areas in which case counts appear to be stable or slowly declining.Competing Interest StatementThe authors have declared no competing interest.Funding StatementLW and TCP are funded by NIH/NIGMS grant R01 GM130900-01A1 to the University of California, San Francisco.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this manuscript is publicly available from the New York Times and other sources, all linked in the manuscript.